Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/23/2012 | CA2827585A1 Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases |
08/23/2012 | CA2827488A1 Methods for controlling pain in equines using a transdermal solution of fentanyl |
08/23/2012 | CA2827470A1 Transdermal delivery system containing galantamine or salts thereof |
08/23/2012 | CA2827435A1 Methods for controlling pain in canines using a transdermal solution of fentanyl |
08/23/2012 | CA2827432A1 Process for preparing products comprising stabilised actives and compositions comprising same |
08/23/2012 | CA2827373A1 Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea |
08/23/2012 | CA2827299A1 Liquid propellant-free formulation comprising an antimuscarinic drug |
08/23/2012 | CA2827289A1 Absorbent dressings with painkilling activity |
08/23/2012 | CA2827273A1 Technology for preventing abuse of solid dosage forms |
08/23/2012 | CA2826999A1 Pharmaceutical preparation containing selenite or selenite-containing compounds for the treatment of cervical dysplasias or carcinomas |
08/23/2012 | CA2826865A1 Cefuroxime safety delivery system |
08/23/2012 | CA2826074A1 Pharmaceutical formulation for topical administration comprising b220 |
08/23/2012 | CA2825991A1 Extended release powder and aqueous suspension comprising methylphenidate |
08/23/2012 | CA2825917A1 Filmcoated solid dosage forms comprising honey in the coating |
08/23/2012 | CA2824639A1 A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion |
08/22/2012 | EP2489735A1 Aptamer capable of binding to viral hemorrhagic septicemia virus |
08/22/2012 | EP2489653A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same |
08/22/2012 | EP2489652A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same |
08/22/2012 | EP2489352A1 Medicaments for inhibiting thrombosis |
08/22/2012 | EP2489349A2 Pancreatin pellets, in particular pancreatin micropellets and method for producing same |
08/22/2012 | EP2489348A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
08/22/2012 | EP2489347A1 Process for the production of injectable preparations of phloroglucinol and the injectable preparations so obtained |
08/22/2012 | EP2489346A1 Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases |
08/22/2012 | EP2489340A1 Adhesive patch |
08/22/2012 | EP2489339A1 Method and device for producing adhesive patch |
08/22/2012 | EP2489338A1 Dry wound dressing and drug delivery system |
08/22/2012 | EP2488637A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods |
08/22/2012 | EP2488572A1 Method for preparing a recyclable polyamide powder |
08/22/2012 | EP2488206A1 Porphyrin nanovesicles |
08/22/2012 | EP2488197A1 Th1/th2 polarizing vaccines |
08/22/2012 | EP2488173A1 Delayed release compositions |
08/22/2012 | EP2488167A2 Carbohydrate entrapped active agent delivery composition and articles using the same |
08/22/2012 | EP2488166A2 Transdermal therapeutic systems containing 4-n-butylresorcinol |
08/22/2012 | EP2488165A1 Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy |
08/22/2012 | EP2488164A2 Release of agents from cells |
08/22/2012 | EP2488163A1 A delayed release pharmaceutical composition of mesalamine |
08/22/2012 | EP2488162A2 Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof |
08/22/2012 | EP2488161A2 Anti-misuse solid oral dosage form provided having a modified specific release profile |
08/22/2012 | EP2488160A1 Liposomal amphotericin formulation comprising cholesterol for treating fungal infections |
08/22/2012 | EP2488159A2 Emergency contraceptive |
08/22/2012 | EP2488157A1 Improved formulations |
08/22/2012 | EP2488156A1 Compositions and methods for mild sedation, anxiolysis and analgesia in the procedural setting |
08/22/2012 | EP2488034A1 Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application |
08/22/2012 | EP2488023A2 Antimicrobial composition |
08/22/2012 | EP2488018A1 Methods and compositions for novel liquid crystal delivery systems |
08/22/2012 | EP2187876B1 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
08/22/2012 | EP2175834B8 Glp-1-fc fusion protein formulation |
08/22/2012 | EP2156820B1 Skin whitening agent |
08/22/2012 | EP2046121B1 Fatty acid pharmaceutical foam |
08/22/2012 | EP2011488B1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
08/22/2012 | EP2010159B1 Fast release paracetamol tablets |
08/22/2012 | EP1817014B1 Method of providing fast relief to a user of a nicotine chewing gum |
08/22/2012 | EP1803460B1 Use of a platinum colloid containing aqueous solution for the treatment of psychiatric symptoms |
08/22/2012 | EP1742618B1 Liquid oral formulations of ospemifene |
08/22/2012 | EP1732524B1 Methods and compositions for treatment of ion imbalances |
08/22/2012 | EP1694370B1 Wound care products containing keratin |
08/22/2012 | EP1667667B1 Hydrogel compositions with an erodible backing member |
08/22/2012 | EP1663252B1 Application assembly for medicaments that are to be applied to the skin and packaging that is used as an application assembly |
08/22/2012 | EP1526838B1 Intravenous pharmaceutical form of administration |
08/22/2012 | EP1487426B1 Methods of inducing terminal differentiation |
08/22/2012 | EP1399032B2 Improved hard sugar coating method |
08/22/2012 | EP1051978B1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
08/22/2012 | CN1935146B Anti-cytochrome oxidase P450 inhibitor medicinal composition and its use |
08/22/2012 | CN1803787B Hypericum perforatum L. total flavone extracts, its preparation and application |
08/22/2012 | CN1449825B Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof |
08/22/2012 | CN102648264A Thickening or gelling agent for oily raw materials |
08/22/2012 | CN102648005A Carrier |
08/22/2012 | CN102648004A Photosensitizing compositions |
08/22/2012 | CN102647997A Inhibiting bacterial infection and biofilm formation |
08/22/2012 | CN102647990A Methods of attenuating the loss of functional status |
08/22/2012 | CN102647980A Stable fat-soluble active principle particles |
08/22/2012 | CN102647979A Diketopiperazine microparticles with defined specific surface areas |
08/22/2012 | CN102647978A Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer |
08/22/2012 | CN102647977A Formulation of drugs and vaccines in the form of percutaneous injectable needles |
08/22/2012 | CN102643333A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
08/22/2012 | CN102643308A Oxaliplatin crystal compound and freeze-dried powder injection |
08/22/2012 | CN102643251A Linezolid degradation impurity and preparation method thereof |
08/22/2012 | CN102643214A Preparation method and preparation of vorinostat I crystal form large grains |
08/22/2012 | CN102641519A Preparation method of external fixation plaster for treating fracture before moulding |
08/22/2012 | CN102641509A Application of Epstein barr (EB) virus miR-BART7 antisense oligonucleotide in preparing medicine capable of treating nasopharynx cancer |
08/22/2012 | CN102641504A Heat-resistant freeze-drying protecting agent for vaccine and preparing method |
08/22/2012 | CN102641494A Traditional Chinese medicine externally-applied plaster for treating chronic bronchitis |
08/22/2012 | CN102641490A Medicinal extract for treating facial nerve paralysis |
08/22/2012 | CN102641462A Traditional Chinese medicine for treating chronic cholecystitis, preparation method and application |
08/22/2012 | CN102641461A Plaster and preparation method thereof |
08/22/2012 | CN102641460A Traditional Chinese medicine pill for treating pathological fracture and preparation method thereof |
08/22/2012 | CN102641458A Preparation method for medicated implanted catgut sutures for treating neck, shoulder, waist and leg pain and spinal diseases |
08/22/2012 | CN102641439A Compound propolis composition for curing chicken infectivity throat bronchitis and preparation method thereof |
08/22/2012 | CN102641434A Capsule capable of promoting blood circulation, removing meridian obstruction and removing paralysis and preparing technology thereof |
08/22/2012 | CN102641433A Plaster for treating tumors and osteopathy and manufacturing method of plaster |
08/22/2012 | CN102641421A Figwort Shangqing gula tablet |
08/22/2012 | CN102641412A Root-securing and panting-calming granule and preparation process thereof |
08/22/2012 | CN102641407A Preparing method and detecting method for fructus trichosanthis granules |
08/22/2012 | CN102641404A Ointment for skin surgical infection |
08/22/2012 | CN102641402A Preparation and quality control method of traditional Chinese medicine compound preparation for treating nephritis |
08/22/2012 | CN102641401A Suppository for reducing early pregnancy and reducing sequelae by administration through vagina |
08/22/2012 | CN102641397A Sheep placenta-containing composite capsule and preparation method thereof |
08/22/2012 | CN102641393A Traditional Chinese medicine composition for treating apoplexy |
08/22/2012 | CN102641390A Traditional Chinese medicine injection for treating diseases in triple warmer, heart channel and pericardium channel |
08/22/2012 | CN102641388A Traditional Chinese medicine cream for treating arthralgia |